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Abstract

Several studies showed the effects of glucocorticoid hormones on the hippocampus.
It has been reported that the chronic administration of high dose glucocorticoids
(GC) results in the degeneration of pyramidal neurons. However, bilateral
adrenalectomy has been shown to damage the hippocampal neurons. Although the
effects of long-term adrenalectomy have been studied extensively, there are few
publications on the effects of short-term bilateral adrenalectomy (ADX). We aimed
to investigate the effects of ADX on levels of pro-inflammatory cytokines
interleukin-1β (IL-1β), interkeukin-6 (IL-6) and tumor necrosis factor-α (TNF-α);
levels of growth factors, response of microglia and astrocytes to neuronal death, and
oxidative stress markers; reduced glutathione (GSH), catalase (CAT) and
malondialdehyde (MDA) over the course of time (0.5, 2, 4, 12 hours, 1, 3, 7, 14
days) in hippocampus of male Wistar rats.
Results showed significant elevation of pro-inflammatory cytokines IL-1β at 4 hours,
1, 3, 7 days, whereas, IL-6 was significantly increased at 2 and 4 hours, 1 and 3 days
in ADX compared to sham rats. After 7 days, elevation of both cytokines returned to
control levels. However, TNF-α levels were significantly elevated at 2, 4 and 12
hours and 14 days in adrenalectomized compared to sham rats.
A significant decrease of insulin-like growth factor-1 (IGF-1) levels was observed at
12 hours after ADX and remained consistent at 1, 3, 7, and 14 days compared to
sham rats. However, β-nerve growth factor (NGF) was significantly reduced in
ADX compared to sham rats only at 14 days.

viii
A time dependent increase in degenerated neurons in the dorsal blade of the dentate
gyrus (DG) was observed from 3 to 14 days after ADX. An early up-regulation of
microglia was observed on day three, whereas, increase in astroglia in the
hippocampus was observed at 7 days ADX. After 14 days of ADX we observed a
progression of microglia and astroglia up-regulation all over the DG of
adrenalectomized rats’ hippocampi compared to sham rats.
The antioxidant CAT increased at 3, 7 and 14 days in an effort to protect the neurons.
However, oxidative stress was manifested in the ADX compared to the sham rats due
to significant decrease of GSH after 7 and 14 days, with a simultaneous increase of
MDA, after 7 and 14 days of ADX.
Taking these findings together, we suggest that the early inflammatory components
and loss of growth factors might contribute to the initiation of the biological cascade
responsible for subsequent hippocampal neuronal cell death in the current
neurodegenerative animal model.

Keywords: Glucocorticoids, adrenalectomy, oxidative stress, growth factors, proinflammatory cytokines, microglia, astrocytes, neurodegeneration, hippocampus.
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)Title and Abstract (in Arabic

دراسة تأثير االستئصال الثنائي للغدد الكظرية على المدى القصير  :التغيرات
البيوكيميائية والشكلية في منطقة الحصين في الجرذان

الملخص
تناولت العديد من الدراسات تأثير هرمونات الجاليكورتيكود على منطقة الحصين في
المخ  ،وتبين أن التعرض لجرعات عالية من هرمونات الجاليكورتيكود لمدة زمنية طويلة يؤدي
إلى موت الخاليا العصبية الهرمية  .كما تبين أن االستصصا الثنائي للغدة الكظرية يضر الخاليا
العصبية في الحصين  .بالرغم من أن آثار استصصا الغدة الكظرية على المدى الطويل قد تمت
دراستها على نطاق واسع  ،إال أن عددا قليال من الدراسات تناولت آثار استصصا الغدة الكظرية
على المدى القصير  .باإلضافة إلى ذالك  ،إن الهدف من هذه الدراسة هو البحث عن آثار
االستصصا الثنائي للغدة الكظرية على المدى القصير على مستويات السيتوكينات المحفزة
لاللتهاب مثل سيتوكينات ( IL-1βو  IL-6و  ، )TNF-αومستويات عوامل النمو  .كما تركز
الدراسة على استجابة الخاليا غير العصبية ( )Microglia & Astrocytesلموت الخاليا
العصبية  ،و تأثير عملية اإلجهاد التأكسدي مثل الجلوتاثيون ( )GSHونشاط إنزيم الكاتاليز
( )CATوالملونديالديهايد ( . )MDAوتتابع الدراسة هذه التأثيرات في منطقة الحصين من مخ
ذكور الجرذان من نوع ويستار ( )Wistarعلى فترات زمنية مختلفة وهي ( 0.5و  2و  4و
 12ساعة و  1و  3و  7و  14يوما) بعد االستصصا الثنائي للغدة الكظرية .
وقد أظهرت نتائج الدراسة ارتفاعا كبيرا في مستويات السيتوكينات المحفزة لاللتهاب ؛
حيث لوحظ ارتفاع مستوى  IL-1βبعد  4ساعات وخال بعد  1و  3و  7أيام من االستصصا
الثنائي  ،في حين أن مستوى  IL-6تزايد بشكل ملحوظ بعد  2و  4ساعات وخال  1و  3أيام

x

في الجرذان التي استصصلت منها الغدد الكظرية ( )ADXمقارنة بالجرذان التي أجريت لها
العملية دون أن يتم االستصصا ( . )Shamوبعد  7أيام لوحظ أن هذا االرتفاع في مستوياتIL-
1βو IL-6يعود إلى مستويات مجموعات ( )Shamمن الجرذان  .أما مستويات
سيتوكين  TNF-αفقد ارتفعت بشكل كبير بعد  2و  4و  12ساعة وكذلك بعد  14يوما من
الجراحة المطبقة على جرذان مجموعات ( )ADXمقارنة بجرذان مجموعات (. )Sham
وقد لوحظ انخفاض كبير في مستويات بروتين  IGF-1ابتداء من  12ساعة بعد
االستصصا ( )ADXواستمر ثابتا بعد  1و  3و  7و  14يوما من الجراحة مقارنة بجرذان
مجموعات ( . )Shamأما مستويات بروتين ( )βNGFفقد انخفضت بشكل ملحوظ في
مجموعات ( )ADXمقارنة بمجموعات ( )Shamبعد  14يوما فقط من الجراحة.
وقد أظهرت الدراسة ارتفاع تدريجي في موت الخاليا العصبية في الشفرة الظهرية
للتلفيف المسنن ( )dentate gyrusمن الحصين بعد  3أيام ولغاية  14يوما من استصصا الغدة
الكظرية  .وقد لوحظ زيادة مبكرة في نشاط الخاليا الدبقية الصغيرة ( )Microgliaفي اليوم
الثالث بعد الجراحة  ،في حين لوحظ ازدياد نشاط الخاليا النجمية ( )Astrocytesفي الحصين
بعد  7أيام من االستصصا ( . )ADXأما بعد  14يوما من الجراحة فقد ازداد نشاط الخاليا غير
العصبية الدبقية الصغيرة ( )Microgliaوالنجمية ( )Astrocytesليشمل جميع أنحاء التلفيف
المسنن ( )dentate gyrusمن الحصين في مجموعات ( )ADXمقارنة بمجموعات
(.)Sham
وقد زاد نشاط إنزيم الكاتاليز ( )CATالمضاد لألكسدة بعد  3و  7و  14يوما من
الجراحة في محاولة لحماية الخاليا العصبية من اإلجهاد التأكسدي الذي ظهر بوضوح في
مجموعات ( )ADXمقارنة بمجموعات ( )Shamبسبب االنخفاض الكبير في مستويات
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الجلوتاثيون ( ، )GSHوكذلك ارتفاع مستويات الملونديالديهايد ( ) MDAالدالة على اختال
الغشاء البالزمي للخاليا بعد  7و  14يوما من الجراحة .
بنا ًء على ما سبق  ،فقد أظهرت الدراسة أن االستصصا الثنائي للغدة الكظرية على
المدى القصير يؤدي إلى ارتفاع مبكر في مستويات السيتوكينات المحفزة لاللتهاب  ،وانخفاض
في عوامل النمو متبوعا بموت الخاليا العصبية وزيادة نشاط الخاليا غير العصبية إضافة إلى
زيادة اإلجهاد التأكسدي في منطقة الحصين  .وبناء على هذه النتائج يمكن أن نستنبط أن حدوث
االلتهاب في وقت مبكر وفقدان عوامل النمو يسهم في بدء سلسلة من العمليات البيولوجية
المسؤولة عن موت الخاليا العصبية في الحصين في هذا النموذج الحيواني التجريبي لموت
الخاليا العصبية  .ومن ثم يمكن التكهن بأنه في العديد من أمراض موت الخاليا العصبية مثل
مرض الزهايمر؛ قد تؤدي الزيادة المزمنة في هرمونات الغدة الكظرية  -مع  /أو انخفاض
مستقبالتها  -إلى نشوء آليات التهابية وفقدان عوامل النمو مثل  IGF-1مما ينتج عنه موت
الخاليا العصبية في الحصين.

مفاهيم البحث الرئيسية :جاليكورتيكود  ،استصصا الغدة الكظرية  ،اإلجهاد التأكسدي  ،عوامل
النمو  ،السيتوكينات المحفزة لاللتهاب  ،الخاليا الدبقية الصغيرة  ،الخاليا النجمية  ،موت الخاليا
العصبية  ،الحصين .
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Chapter 1: Introduction
1.1

Historical Evolution of the Hippocampus

1.1.1

Origin of Name

History recalls the earliest description of the hippocampus located in the
temporal horn of the lateral ventricles, by anatomist Julius Caesar Arantius in 1587
in his book “De Humano Foetu” as a seahorse. The origination of the word came
from Greek hippos “horse” and kampos “sea monster” (Bir et al., 2015). However,
Arantius lacked the foresight to illustrate his observation. Future scholars were
consequently confused as to how this anatomical structure could be perceived
(Lewis, 1923).

Figure 1: Human hippocampus compared with a seahorse

Less than two centuries thereafter, in 1729, anatomist Duvernoy was the first
to draw the structure of the hippocampus (P. Andersen et al., 2006; Duvernoy et al.,
2013). In 1732, Jacques Benigne Winslow proposed the term “ram’s horn”. Later in
1742, the surgeon de Garengeot used a more mythical term “cornu Ammonis” (CA)–
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horn of an ancient Egyptian god Ammon. The meaning behind the name was “the
hidden”; the god was presented as a ram headed man or sphinx (Olry & Haines,
1998; Pearce, 2001; El-Falougy & Benuska, 2006).

1.1.2

Architecture of the Hippocampus

Pierre Tarin in 1750 differentiated in the hippocampus what he called the
“dentate fascia” or the DG (El-Falougy & Benuska, 2006). When Felix Vicq d’Azyr
identified the hippocampus major and minor in the 18th century, it sparked a
hippocampus debate, also known as the Huxley-Owen debate (Bentivoglio &
Swanson, 2001). In the 19th century, the two anatomists argued if either of their
anatomic findings agreed or opposed Darwin’s theory of evolution; whether the
human brain was unique compared to the brain of apes, in terms of containing a
hippocampus minor “calcar avis”. It was later settled in favor of Huxley and Darwin
(Owen et al., 2009).

Figure 2: Golgi stain of rat hippocampus

In 1873, Golgi discovered a method to understand the nervous system
(Swanson, 1999). He introduced silver nitrate impregnation – black reaction, via
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microscopic explorations that was modified by Ramon y Cajal and his student,
Rafael Lorente de No, to study the cellular architecture of the hippocampus (Ramón
y Cajal, 1909). They described the cells and their components in the hippocampus
and the two divisions of this structure based on the recurrent circuitry in the
pyramidal cell layer. They further defined the properties of small CA1 and large CA3
pyramidal neurons. It was Lorente de No that coined the terminology for the
sections; CA1-CA4 (Lorente De Nó, 1934; P. Andersen et al., 2006; Bartsch, 2012).

Figure 3: Structure of rat hippocampus

James Papez, in 1937, reported a center of emotion in the hippocampus that
was articulated in a circuit. The Papez circuit constitutes of a group of neural
projections involved in memory and emotional expression that originates in the
cortex and subsequently communicates with the hippocampal formation in the
subiculum, in which the mammillary bodies receive a dense input via the fornix. The
mammillary bodies in turn project via the mammillo-thalmic tract to the anterior
thalamic nucleus, and finally to the cingulum which eventually leads back to the
hippocampal formation (Vann & Nelson, 2015; Li et al., 2016). However, MacLean
proposed the Papez circuit as part of the limbic system by including the amygdala
and septum (MacLean, 1952). Ultimately, in 1998, the Federative Committee on
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Anatomical Terminology settled to designate to the term hippocampus as
“Hippocampus proper” and/or “Ammon's horn”.

1.2

Anatomy
The cerebral cortex is part of the grey matter and composed of un-myelinated

nerve cells. It is responsible for higher brain functions, such as; consciousness,
language, information processing, sensation, and memory. The outer region of the
cerebral cortex is the neocortex folded in cortical structures; the frontal, parietal,
occipital, and temporal lobes (Kande et al., 2000; Mai et al., 2015).

Figure 4: Human brain anatomy

In the fully developed human brain, the hippocampi extend the length of the
floor of the inferior horn of the lateral ventricles, which traverse the temporal lobe.
The hippocampus is structurally and functionally distinct and has 3 layers; dendrite,
pyramidal cell, and axon, that connect to the 6 layers of the neocortex by receiving
main afferences from the entorhinal cortex (EC) and sending efferences to other
areas through the subiculum (Waxman, 2013).
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Figure 5: Human hippocampus

The EC is divided into medial entorhinal cortex (MEC) and lateral entorhinal
cortex (LEC) areas. It has 6 layers; neurons in layers 2 and 3 send projections to the
hippocampus, DG, and subiculum, while neurons in layers 5 and 6 receive feedback
from CA1 and subiculum (Scharfman, 2011). Much of the hippocampal formation
lies in the floor of the temporal horn of the lateral ventricles. It is composed of the
DG, CA subfields 1-4, and subiculum.

1.2.1

Hippocampal Layers

The DG has 3 layers: polymorphic layer, stratum moleculare contains
proximal dendrites of the granule cells, and stratum granulosum contains the cell
bodies of granule cells and is the principal layer.
The CA has 7 layers: stratum moleculare, stratum lacunosum, stratum
radiatum, stratum lucidum, stratum pyramidale, stratum oriens, and stratum alveus.
The stratum pyramidale is the principal layer containing the cell bodies of the
pyramidal cells. It is divided into four subfields: CA1, CA2, CA3, and CA4. The
CA1 region neighbors the subiculum – the inferior part of the hippocampus. The
CA3 region is adjacent to the choroid plexus and the fornix. The CA2 region is a
boundary between CA1 and CA3, and CA4 is sited in the hilus of the DG – the
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inside portion of the DG. The hippocampal fissure is a cell-free natural division that
separates the DG from the CA1 region (Taupin, 2008).

Figure 6: Layers of human hippocampus

1.2.2

The Circuit

The major hippocampal pathways are organized in a trisynaptic circuit; a
transverse strip along the septotemporal axis of the hippocampus, with information
flowing in a unidirectional way. The trisynaptic circuit was first described by Ramon
y Cajal using the Golgi stain method (P. Andersen, 1975). Later, using anatomical
and physiological evidence, Per Andersen proposed that thin slices (lamella) could
be cut out of the hippocampus perpendicular to its septotemporal axis while
preserving all of the synaptic connections. This led to the lamellar hypothesis in
which one could assume the hippocampus to be a series of parallel strips operating in
an independent manner (P. Andersen et al., 1969; Amaral & Witter, 1989; P.
Andersen et al., 2000).
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The circuit begins with the first synapse; axons of pyramidal cells of the layer
2 of EC project to the granule cells of the DG by the perforant pathway. The second
synapse occurs when axons of granule cells in the DG project to the dendrites of the
pyramidal cells of CA3 by the mossy fibers pathway. The third and final synapse
allows pyramidal cells of CA3 to project to pyramidal cells of CA1 through
collaterals of Schaeffer. The CA1 completes the circuit by feedback to layer 5 of the
EC (Eichenbaum, 2004; Taupin, 2008).

Figure 7: Trisynaptic circuit

However, subsequent neuroanatomical investigations have revealed that
hippocampal projections are much more divergent than would be consistent with a
strict interpretation of the lamellar hypothesis (Sloviter & Lømo, 2012).There are
other intrinsic connections of the hippocampal formation such as: neurons in layer 2
of EC project to the CA3 field via the perforant pathway; neurons from layer 3 of the
EC project to CA1 and subiculum via perforant and alvear pathways; CA3 pyramidal
cells project heavily onto themselves through recurrent collaterals; CA3 neurons
project back to the DG via the hilar mossy cells as feedback; and pyramidal cells in
CA1 project to subiculum, then back to EC (Witter, 1993; P. Andersen et al., 2006).
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The hippocampal trisynaptic circuit has a well-established role in information
processing. It is the main route through which activity flows; information enters the
EC from a specific cortical area and can cross the hippocampal circuit via the
excitatory pathways and eventually be returned to the cortical area from which it
instigated (Nicoll & Schmitz, 2005; Nakashiba et al., 2008; Neves et al., 2008;
Daumas et al., 2009). This transformation is presumably essential for enabling the
information to be stored as long-term memories.

1.3

Physiology

Studies have shown varied views and perspectives emphasizing prominent
features of the hippocampus (Marr, 1971; O'Keefe & Nadel, 1978; Sapolsky, 1996;
McNaughton et al., 1996; Leutgeb et al., 2007). It was thought that the function of
the hippocampus was to some extent limited to the regulation of olfaction. A
characteristic feature of odor memory is to recall emotional experiences; with direct
connections between the olfactory bulb and the amygdala and hippocampus (Mouly
& Sullivan, 2010). Yet, with the discoveries of Paul Broca and James Papez in
identifying the hippocampal formation as part of the limbic lobe and representing the
Papez circuit, respectively (Purves et al., 2001), it was broadly and supportably
explored as a regulator of emotional behavior.

1.3.1

Declarative Memory

The hippocampus serves a critical role in declarative (explicit) memory –
ability to recall everyday facts and events (Squire, 1992). A case study of patient
H.M. provided critical information about the hippocampus. H.M. was an epileptic
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patient with severe seizures. They began when he was 10 years old, and by the age of
27 his attacks prevented him from living a normal life. Scoville executed an
experimental surgery, the bilateral resection of the medial temporal lobes, thus
assuaging his epileptic seizures. However, H.M. became amnesic for the rest of his
life. He could no longer store new memories. Yet, those before the operation
remained intact. He also could not transfer new explicit memory into long term
memory. Although, his ability to form new long term implicit memories remained
unharmed (Scoville & Milner, 1957; Corkin, 1984). It was concluded that H.M. had
severely impaired declarative memory, but his perceptual and cognitive abilities were
intact, as were his capacities for working memory and perceptual and motor skill
learning (Milner et al., 1968; Eichenbaum, 2004). Yet, it was Brenda Milner and
Wilder Penfield that first presented in 1955 at the Transactions of the American
Neurological Association with information of the effects of the hippocampal damage
on memory in humans (Milner & Penfield, 1955).
In the early 1950’s, Penfield began to treat patients for localized injuries that
were causing seizures by removing parts of the temporal lobe. However, Milner and
Penfield found impairments similar to H.M. – severe, persistent, and generalized
damage to recent memory without intellectual loss – in two patients after left
temporal lobectomy. To interpret the unexpected memory loss, they hypothesized
pre-existing lesions to the hippocampal region of the right hemisphere, that were
later confirmed with one of the patients’ death (Penfield & Mathieson, 1974; Milner
et al. , 1998). It was in 1955 that Scoville asked Milner to examine his patient that
started five decades of experimental studies on H.M. (Donkelaar, 2011).
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1.3.2

Spatial Memory and Navigation

Besides its role in memory, the hippocampus plays an important part in
spatial memory and navigation. Edward Tolman in 1948 presented the concept of a
cognitive map by observing rats performing maze tasks. He held the notion that rats
learn to navigate mazes by establishing a field map of the environment to reach the
prize by means of the shortest route from any certain location (Tolman, 1948; Best &
White, 1999). It was not until 1971, O'Keefe and Dostrovsky together discovered the
place cells by recording the pyramidal neurons in the CA1 region of the
hippocampus of freely moving rats in a bounded area (O'Keefe & Dostrovsky, 1971).
O’Keefe and Nadel in 1978 finally established that the hippocampus might act as a
cognitive map; a neural representation of the layout of the environment, and they
were able to locate these cells (O'Keefe & Nadel, 1978; Burgess et al., 2002). They
inserted microelectrodes into different regions of the hippocampus of the rat to
record activity. For example; placing a rat in a maze will record the location of
activity in the brain that corresponded to where the animal is positioned. These
hippocampal neurons became known as “place cells” located in the CA1 region
(Corballis, 2014). They fire specifically in patterns known as place fields,
corresponding to regions of sensory information in the environment (Leutgeb et al.,
2005). When a rat is placed in a fixed environment, spatial firing of place cells
becomes intense and rapid. This occurs as the rat’s head is inside a cell-specific
region or a firing field (Muller & Kubie, 1987).
Place fields have the ability to change their firing patterns and rates by
responding collectively and consistently to large sensory inputs while resisting small
changes to the external environment; this is known as remapping – critical for pattern
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separation, as it involves transforming an overlapping input pattern into a nonoverlapping output, hence, distinguishing memories from one another (Cressant et
al., 2002; Jeffery, 2007). These nerve cells in the brain enable a sense of place and
navigation and the ability to store information about the environment as a memory
(O'Keefe & Conway, 1978).
What May-Britt Moser and Edvard Moser discovered in the medial EC were
“grid cells”. They provide the brain with an internal coordinate system essential for
navigation (Hafting et al., 2005). These scientists obtained recordings from a
different part of the EC; the medial entorhinal cortex (Fyhn et al., 2004). In the first
study, they established the presence of certain cells sharing characteristics similar to
place cells. In a later study they experimented using larger encounters for the animals
to move in, which led them to the discovery of grid cells.
Both discoveries present a hypothesis of how specialized cells can work
together to accomplish higher cognitive functions (Moser et al., 2008). Such as, the
replay of the activity of place cells during sleep may possibly be a memory
consolidation mechanism, where the memory is finally stored in cortical structures.
The course by which this might occur is through rapid synaptic modification,
primarily within the hippocampus during a waking experience, whereby information
is acquired during active behavior. During sleep, synaptic modification is suppressed
and the information encoded within the hippocampus is "played back" or reexpressed in circuits by an increase in the firing rate of hippocampal cells; those that
are engaged in place-specific activity. These cells have the ability to retain the
structure of distributed representations of the visited locations as part of a
consolidation process by which hippocampal information is gradually transferred to
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the neocortex (Pavlides & Winson, 1989; Treves & Rolls, 1994; Wilson &
McNaughton, 1994).

1.4

Memory Formation

Memory is the precise storage and recollection of information. The
connection of the hippocampus to memory has made it one of the most studied
structures in the brain. Research has shown that the hippocampus is involved in the
establishment of stable declarative memories; our capacity for the recollection of
unique personal experiences and is involved in the acquisition of semantic or factual
knowledge (Cohen & Squire, 1980). It plays a critical role in short-term memory;
necessary for long-term memory patterns to be formed.
The underlying mechanisms in which the hippocampus contributes to
declarative memory are diverse with differing cognitive processes. When you
experience something, the hippocampus learns the information during this
experience and then plays the memory back repetitively to the cerebral cortex to
formulate a long-term memory, this is consolidation. After a memory has been
encoded, the memory undergoes further consolidation, for example while asleep.
Finally, the stored memory is relocated to other areas of the cerebral cortex, and the
location of encoding of these memories may be a function of the type of memory;
that is they are housed in different areas of the cortex. The hippocampus is not only
active in encoding memories but also in the retrieval of them. There is evidence to
suggest that the hippocampus supports many numerous functions, including, but not
limited to, path integration – the ability of place cells to integrate new information on
movement (Kubie & Fenton, 2009), and stress response (Sapolsky, 1996).
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1.5

The Stress Response

1.5.1

Glucocorticoids

GC or cortisol are hormones secreted in a circadian rhythm. High levels of
cortisol are released once a person awakens and are gradually diminished throughout
the day. This characteristic of cortisol can be affected by a number of psychological
and situational factors. Stress from work has been shown to enhance morning cortisol
release (Steptoe et al., 2003). While in situational factors, it can produce a more
pronounced cortisol response on work days compared to weekends (Kunz-Ebrecht et
al., 2004). GCs are essential for adapting to acute physical stressors; they divert
energy to exercising muscle, enhance cardiovascular tone, suppress digestion,
growth, and reproduction, suppress immune responses that might otherwise spiral
into autoimmunity, and sharpen cognition.
Glucocorticoid hormones are important regulators of hippocampal function
with biphasic effects on memory (Conrad et al., 1999). In 1968, McEwen and
colleagues used bilaterally adrenalectomized rats to see which parts of the limbic
system would uptake and retain circulating radioactive corticosteroids, without the
interference and competition of endogenous corticosteroids. McEwen discovered the
ability of corticosteroids to bind to the hippocampus (McEwen et al., 1968). It was
found that the hippocampus contains the highest concentration of corticosteroid
receptors in the brain and provides a negative feedback mechanism, which modifies
the hypothalamic–pituitary–adrenal axis (HPA) response ( Sapolsky et al., 1984).
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Figure 8: Stress response and HPA axis

During a typical HPA axis stress response, increased availability of
circulating GC leads to corticosteroid receptors occupation; this will reduce the
release of both corticotropin-releasing hormones (CRH) from the hypothalamus and
adrenocorticotropic hormone (ACTH) from the anterior pituitary. The reduction will
inhibit the release of corticosteroids from the adrenal cortex, hence, activating a
negative feedback loop and decreasing the HPA axis response (McEwen, 2000). This
shows how the hippocampus is important to regulate the HPA axis, especially during
stress.
Studies have also investigated the release of corticosteroids to awakening in
patients with lesions in the temporal lobe (Buchanan et al., 2004; Wolf et al., 2005).
They found that damage particularly in the hippocampus does indeed alter the basal
cortisol release, which might in turn be affecting the stress response (Buchanan et al,
2009).
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1.5.2

Memory and Glucocorticoids

The effects of GC on learning and memory have been examined and
experimented on animals, the results supported an inverse-U feature; in the rat, both
adrenalectomy and stress levels of GC impair hippocampal-dependent spatial
learning (Sapolsky, 1999). Studies in rodents have shown that persistently raised GC
have the ability to damage hippocampal neurons (Gould et al., 1990a), while the
removal of GCs by bilateral adrenalectomy induces neuronal death (Sloviter et .al,
1993).
Adrenal steroids act on intracellular receptors all through the CNS, therefore,
the deletion of GC results in many neurological changes throughout the brain.
Throughout growth, GC regulates growth of the cell, its differentiation, and is able to
inhibit proliferation of the cells (Meyer, 1985). While in the developed brain, GC
diminish the cell death in the hippocampus (Sloviter et al., 1989) and reduce the
morphological alterations after adrenalectomy (Gould et al., 1990a).Undeniably,
adrenal secreted steroids seem to control memory, learning and consolidation, and
influence mood and complex behavioral interactions (McEwen et al., 1986).

1.6

Neurodegeneration

1.6.1

Definition

Neuronal death is recognized in neurodegenerative diseases; however, the
mode is unclear. Of those that are well studied include necrosis; a direct result of the
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excitotoxic activity of glutamate, and apoptosis; dependent on the activation of
apoptotic enzymes – caspases (Gorman, 2008; Czuczwar, 2009).

Figure 9: Necrosis vs. Apoptosis

The term ‘neurodegeneration’ is defined as a chronic and progressive
alteration or loss of structure or function of neurons at an amount that causes the
neurons to be below their functional threshold (Przedborski et al., 2003; Schloesser
et al., 2009).

1.6.2

Neurodegenerative Disorders and Biomarkers

The role of cell death in neurodegenerative diseases remains inexplicable.
Most neurodegenerative disorders have an insidious onset while progressively
afflicting relentless pain for those suffering and their families. By the time a patient
is diagnosed with a neurological illness, widespread neuronal damage has usually
already occurred. Accordingly, there is a great need for the discovery of biomarkers
that allow early diagnosis and intervention (Gazaryan & Ratan, 2009). Researching
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the injured brain has allowed many scientists to study and understand how it works
during pathological situations and extrapolate information on its physiology.
Various neurological and neuropsychiatric diseases with extensive damage
encompassing the hippocampus led scientists to point out the vulnerability of this
region towards pathologies. Magnetic Resonance Imaging (MRI) is a technique used
to help with the neuropsychological analysis of hippocampal impairment, and it has
helped researchers to derive some cognitive processes that are fundamental for
declarative memory (Frisoni et al., 2006). The depictions of neuronal firing patterns
in behavior suggest that the hippocampus elicits elemental cognitive processes for
declarative memory. Many neuropsychiatric diseases have presented abnormalities in
the hippocampus, including Alzheimer’s disease and Parkinson’s disease (PD)
(Theodore et al., 1999; Godsil et al., 2013; Coras et al., 2014).

1.6.3

Alzheimer’s Disease

Alzheimer’s disease (AD) is a neurodegenerative disorder instigated by a
progressive and irreversible destructive process of the limbic system and neocortex
via amyloid plaque and neurofibrillary tangle formation, loss of synaptic function,
mitochondrial damage, activation of microglia and astrocytes, and degeneration of
neuronal processes (Schultz et al., 2004; Crews et al., 2010). Neuronal degradation
occurs gradually in a process that will lead to the deterioration of cognitive functions.
The markers that characterize the development of this process include: amyloid
plaques and neurofibrillary tangles (Thal et al., 2002; Serrano-Pozo et al., 2011).
Neurofibrillary tangles are aggregates of hyper phosphorylated and misfolded tau
that affect CA1 subfields and layer IV of EC (Braak & Braak, 1991). Hippocampal
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circuitry is also compromised; neurofibrillary changes appear in the II layer of EC,
plaques begin to form in the perforant pathway, and in a zone that impacts the
hippocampal afferents. Thus, the hippocampal formation undergoes severe
impairment and is deprived of many afferent and efferent connections leading to an
intellectual decline (Van Hoesen & Hyman, 1990; Braak et al., 2006). O’Keefe and
co-workers 2008 have showed in a mouse model of Alzheimer’s disease that the
degradation of place fields correlated with the deterioration of the animals’ spatial
memory (Cacucci et al., 2008). Yet, there is no immediate translation of such results
to clinical research or practice.
It has been proven by many studies the presence of oxidative stress in AD
brain such as MDA, a by-product of lipid peroxidation (Pratico & Sung, 2004;
Padurariu et al., 2010). The accumulation of antioxidant enzymes such as CAT have
also been observed (Omar et al., 1999). The decline of glutathione due to increased
oxidative damage localized in the synapses has connected the oxidative stress to AD
synaptic loss (Ansari & Scheff, 2010). An index of lipid peroxidation is
thiobarbituric acid reactive substance (TBARS) which was found in the hippocampus
in significantly high levels (Lovell et al., 1995). This data supports the concept of an
Alzheimer’s disease hippocampus being under intense oxidative stress.
More evidence lately is linking cytokines such as IL-1, IL-6, and TNF-α
released from microglial cells to AD pathogenesis. The initiation of a cascade of
neuroinflammation subsequently will contribute to a neuronal damage (Streit et al,
2004; Agostinho et al., 2010). These cytokines such as IL-1, can severely harm
memory at high concentrations and are linked to Alzheimer’s disease (Williamson et
al., 2011). Westwood and colleagues (2014) found that lower levels of IGF-1 are
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associated with an increased risk of developing AD, where higher levels of IGF-1
may protect against subclinical and clinical neurodegeneration (Westwood, et al.,
2014).
Astrogliosis was observed in human tissue and animal models of AD in the
hippocampus (Verkhratsky & Parpura, 2016). An important histological hallmark of
the disease is reactive astrocytes that mainly concentrate around senile plaques found
in the hippocampus; pathological insults to the central nervous system (CNS) trigger
this reaction (Olabarria et al., 2010). These active astrocytes are marked by the
increase in production of glial fibrillary acidic protein (GFAP) (Mandybur &
Chuirazzi, 1990), elevated cytokines (Mrak et al., 1995), and hypertrophy (da Cunha
et al., 1993); this may contribute to the neuroinflammatory response observed in the
hippocampus of AD (Lim et al., 2014; Verkhratsky et al., 2014).
Astrocytes display excitability in the form of intracellular calcium
concentration increases, which trigger release of glutamate (Shigetomi et al, 2008).
The accumulation of calcium in the cytosol is caused by their entry via receptors and
channels that are expressed in astrocytes (Verkhratsky et al., 2012). Calcium
signaling deregulation is considered to be of fundamental importance for cellular
pathology in AD, and the activation of amyloidogenic pathway may function to alter
this signaling pathway; hence, being responsible for the learning and memory
deficits that occur early during the onset of AD (Green et al., 2007; Berridge, 2010;
Grolla et al., 2013). Changes to astrocytes weaken synaptic transmission and affect
neurotransmitter homeostasis among other components of AD; thereby responsible
for cognitive impairment seen initially in AD (Verkhratsky et al., 2010).
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1.6.4

Parkinson’s Disease

Parkinson’s disease is another neurodegenerative disease that shares many
similar characteristics to Alzheimer’s disease including the impairment of declarative
memory (Carlesimo et al., 2012). In PD, we observe the degeneration of dopamine
(DA) neurons in the substantia nigra area of the brain leading to degeneration of the
nigrostriatal pathway, or in other words, a loss of nerve terminals and DA which is
responsible for the movement disorders, i.e., resting tremor, bradykinesia, and
muscle rigidity (Nagatsu et al., 2000a). A key feature of PD is the presence of αsynuclein-positive intracellular inclusions, called Lewy bodies, in DA neurons of
substantia nigra, cerebral cortex, and the hippocampus (Sawada et al., 2006). The
deposition of these Lewy bodies in the hippocampus is correlated to the severity of
cognitive loss in PD patients (Churchyard & Lees, 1997). Non-motor functions such
as behavioral disorders and cognitive impairment support the hippocampus in such
roles and have become recognized as the foremost cause of disability (Voon et al.,
2009; Kehagia et al., 2010). Some of these symptoms occur in early stages of PD
and might have a dopaminergic contribution; constipation, rapid-eye movement sleep
behavior disorder, depression, hyposmia, and anxiety. They were found to draw a
parallel with the progression of PD pathology (Chaudhuri & Schapira, 2009;
Hanganu et al., 2014).
Emerging data suggest an interaction between dopaminergic systems and the
hippocampus and their role in modulating synaptic plasticity of the hippocampus in
memory of PD patients (Calabresi et al., 2013; Foo et al., 2016). The main role of
DA in hippocampal synaptic plasticity and memory is long-term potentiation (LTP)
in the CA1 region aided by D1/D5 dopamine receptor activation (Hansen &
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Manahan-Vaughan, 2014). Another crucial role of DA is the activation of the same
receptors on the dendrites of DG neurons accompanied by high-frequency activity of
these cells; it will lead to potentiation of the synapses essential for LTP, therefore,
affecting spatial memory formation (Hamilton et al., 2010). An interaction between
DA and neurotrophic factors occurs in different phases of hippocampal LTP. Many
studies show that there is an effect of nerve growth factor (NGF) on DA. One
evidence demonstrates that a cortical devascularizing lesion leads to changes in DA
levels in the brain, that can be reversed with intraventricular NGF treatment
(Maysinger et al., 1992). Further, this effect was also seen in the hippocampus
(Paredes et al., 2007). Other studies of neurotrophic factors include in vitro studies to
determine the effect of IGF-1 on dopaminergic neurons and show support to the
survival of these neurons (Knusel & Hefti, 1991). The literature on these growth
factors and their involvement in neurodegenerative diseases have been recently
expanded and more data is needed to fill in the gap to understand their
neuropathology in human diseases (Siegel & Chauhan, 2000). Many reports show
evidence of elevated cytokines levels, oxidative stress, activated microglia, and
advanced neuronal loss (Lull & Block, 2010). Neurodegeneration occurs due to the
activation of microglial cells that elevate the levels of cytokines, such as TNF-α, IL1β, IL-6 and decrease growth factors such as, NGF (Sriram et al., 2006).
Neuroinflammation and oxidative stress may render dopaminergic neurons
vulnerable to cell death in PD possibly by triggering the activation of microglial cells
(Tieu et al., 2003; Hald & Lotharius, 2005; Miller et al., 2009). Activated microglia
observed in the hippocampus of PD patients has shown to have multiple roles; they
can phagocytose damaged cells, produce TNF-α, IL-6, IL-1β, superoxide anions, and
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neurotrophins. This will promote the neurodegeneration progression (Imamura et al.,
2005; Sawada et al., 2006).
The role of astrocytes in PD has not been well understood (McGeer &
McGeer, 2008). Research has linked the protein α-synuclein to hippocampus of PD.
It is released into the extracellular space and can be taken up by astrocytes which
may explain the continuous spread of pathology in PD. The increasing α-synuclein
pathology in hippocampal dysfunction was observed in patients with PD and
contributes to dementia (Lee et al., 2010; Regensburger et al., 2014; Hall et al.,
2014).

Studies

have

suggested

an

early

hippocampal

involvement

in

PD, nonetheless, changes underlying the initial stages of memory and cognitive
impairment in PD are yet to be well understood (Bruck et al., 2004; Tam et al.,
2005).

1.7

Pro-Inflammatory Cytokines

Stressors have the ability to influence the immune system; both innate and
acquired immunity (Chrousos, 2009). Innate immunity works within hours of a
stressor and includes granulocytes, natural killer cells, and pro-inflammatory
cytokines, such as IL-1β, IL-6, and TNF-α. While acquired immunity takes longer
and involves lymphocytes, and other cytokines, such as interleukin-2, interleukin-4,
and interleukin-10. The major pro-inflammatory cytokines, IL-1β, IL-6, and TNF-α,
stimulate the stress system by acting on the hypothalamus to release CRH, on the
pituitary to release ACTH, and on the adrenal cortex to release cortisol (Nussdorfer
& Mazzocchi, 1998; Fink, 2010). This will eventually lead to the suppression of
these cytokines (Chrousos, 1995). However, these cytokines are able to induce a
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“sickness behavior”; fever, fatigue, decreased libido, and loss of appetite, during
systemic infection and inflammation (Elenkov & Chrousos, 1999; Dantzer, 2001).
Cytokines are signaling molecules classified into interleukin, tumor necrosis factor,
interferon, and chemokine. Their receptors are located in many parts of the brain
including the hippocampus (Gardoni et al., 2011). Thus, cytokines are important for
hippocampal functions; learning, memory, and cognitive processes (Vitkovic etal.,
2000; Arisi, 2014).
IL-1β is key for synaptic plasticity in the hippocampus to maintain LTP
(Schneider et al., 1998). It is produced by glia and neurons and their receptors are
localized on the granule cells in the DG. Interleukin-1 may therefore play a crucial
role in the CNS (Ban et al., 1991; Ross et al., 2003). Whereas, at pathophysiological
levels, IL-1 can cause memory impairment; either by blockade of IL-1 signaling or
by impairing Ca2+ influx via block of postsynaptic n-methyl-daspartate (NMDA)
receptors in the DG (Coogan & O'Connor, 1997; Goshen et al., 2007).
IL-6 is mainly synthesized by astrocytes, but also by microglia and neurons
(Oh et al., 2010). Recent studies have explored the role of IL-6 on LTP. By blocking
IL-6 after a spatial alteration that is hippocampus dependent, it led to an
improvement of long-term memory (Balschun et al., 2004). This study and others
have indicated to the negative regulatory role of IL-6 in the CNS, specifically the
hippocampus (Campbell et al., 1993; Steffensen et al., 1994). One research showed
the ability of IL-6 at high levels to cause neuronal death to developing cerebellar
granule neurons (Conroy et al., 2004).
TNF-α is secreted by astrocytes and has a role in preserving synaptic strength
by

enhancing

surface

expression

of

glutamate

amino-hydroxy-methyl-
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isoxazolepropionic acid (AMPA) receptors (Beattie et al., 2002). TNF-α at
pathophysiological levels in hippocampal synapses can inhibit the induction of LTP
and this may relate to the inhibition of Ca2+ influx or its effect on activation of p38
mitogen-activated protein kinase (MAPK)-dependent mechanism (Cunningham et
al., 1996; Barone & Feuerstein, 1999).
Inflammatory Cytokines activate glial cells which in turn have the ability to
produce more cytokines; as a result, glial cells undergo gliosis due to TNF-α and IL1β. Cytokines are not only produced in the CNS, but also peripherally. They are
secreted by T-lymphocytes, natural killer cells, and phagocytes that allow these
cytokines permeability to the blood brain barrier, hence, their contribution to CNS
inflammation (Barone & Feuerstein, 1999).
A study implicated these cytokines to play a role in brain inflammation; by
the expression of TNF-α and IL-1α following a surgical trauma to the hippocampus
(Tchelingerian et al., 1993).

1.8

Growth Factors

The insulin-like growth factors (IGFs) are polypeptides with a sequence
similar to insulin. IGF and IGF receptors are abundantly expressed in the brain where
IGF signaling mediates neuronal growth, migration, regeneration, and repair (de la
Monte, 2013). IGF is a part of a complex system that has an imperative role in
growth and development (Jones & Clemmons, 1995). A number of studies have
implicated IGFs in cognitive functions, and proposed their possible effect on
cognitive improvement and as compounds that may improve cognitive disorders and
even neurodegeneration (Stern et al., 2014).
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Nerve growth factor (NGF) is also a polypeptide found in the CNS in which
the hippocampus contains one of the highest levels of NGF (Shelton & Reichardt,
1986). NGF is an essential neurotrophic factor for the differentiation and survival of
sympathetic neurons (Levi-Montalcini & Angeletti, 1968); it can prompt alterations
in certain neurons, therefore, enhancing neuronal plasticity (Sun et al., 1993). The
hormonal activities of GCs were investigated if they affect the level of NGF in the
hippocampus. It was found that in developing rats, bilateral adrenalectomy
considerably diminished NGF levels in the hippocampus (Aloe, 1989). GC and these
growth factors play important roles in the brain, nonetheless, their interactions
remain unclear and some studies have suggested a relation between them (Sapolsky
et al., 1985; Rotwein et al. 1988; Cheung et al., 1994). The consequence of
permanent loss of corticosteroids due to bilateral adrenalectomy has shown a
neuronal loss in the hippocampus (Adem et al., 1994), yet, information is sparse
about these growth factors in the hippocampus following corticosteroid deprivation.

1.9

Glial Cells

1.9.1

Microglia

Microglial cells originate from the bone marrow; they are derived from
myeloid progenitors that arise at the time of embryogenesis (Ginhoux et al., 2010).
They enter the CNS during early development. In the mature brain they are known as
resting microglia, acting through direct cell-cell contact. Upon the appearance of any
threat towards the CNS they transform to activated forms important to scavenge for
damage and neural protection (Kettenmann et al., 2011; Morriset al., 2013). They
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express NMDA receptors in which when stimulated will increase oxidative stress,
cytokines, and trigger microglia activation all leading to the induction of cell death of
cortical neurons (Kaindl et al., 2012). These receptors and others can be found at
neuronal synapses which can regulate microglial responses to inflammation.

Figure 10: Microglia can become a chronic source of cytokines & ROS

Microglial cells have an important role in memory and learning through their
release of cytokines. In one study by Williamson and colleagues in 2011, they were
able to directly link the microglia as the only source of IL-1β in response to
hippocampus-dependent learning (Williamson et al., 2011).
There has been more evidence that associate different modalities of
microglial interactions with synaptic plasticity; in response to a manipulated sensory
experience such as light deprivation this caused the microglial highly motile
processes to change their morphology and to become less motile. However, light reexposure reversed these behaviors. This contact could be regulated by learning and
memory (Trembla et al., 2010). Other roles include their ability to remove synapses
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by phagocytosis (Tremblay & Majewska, 2011; Morris et al., 2013). Another study
investigated how microglia and neurons interact and play an important role in
cognitive and neuroplasticity processes (Reshef et al., 2014). Fractalkine (CX3CL1)
is a chemokine expressed by neurons in the CNS. It participates in inflammatory
responses by inhibiting microglia activity in many brain disorders. It binds to its
receptor found on microglia in the hippocampus. This signaling pathway has been
implicated in synaptic transmission (Paolicelli et al., 2011; Xu et al., 2012). The
study also shows that the pathway has a part in seizure-induced microglial activation;
providing insight on the role of microglia in neurodegeneration (Ali et al., 2015). An
additional neuroprotective role provided by microglia is the production and secretion
of growth factors like NGF (Nagatsu et al., 2000b). An activated microglia can also
produce reactive oxygen species (ROS) in inflammatory processes leading to
oxidative stress (Fischer & Maier, 2015). A cascade of events will ultimately cause
neuronal death which is a final pathogenic mechanism in neurodegenerative diseases
(Emerit et al., 2004).

1.9.2

Astrocytes

The cell body and the major processes of astrocytes are enriched with GFAP;
an intermediate filament protein that is used to distinguish and identify astrocytes in
the CNS (Nedergaard et al., 2003).
When afferent pathways are activated in the brain, it results in the release of
glutamate, an excitatory neurotransmitter, from synaptic terminals. The released
glutamate exerts its effect on target neurons, while the remaining 80% in the synaptic
cleft activates the astroglial sodium-dependent glutamate transporters to be removed.

28
These transporters control the sodium influx, therefore, increase their concentrations
in astrocytes. This process eventually is responsible for glutamate turnover to prevent
excitotoxicity (Magistretti, 2009). Nonetheless, astrocytes are transporters for many
other ions and water. Other functions include the formation of neurovascular units in
the brain after an increase in neuronal firing, where rapid vasodilation manifests, thus
astrocytes incorporate this neuronal activity with a local blood flow. They also form
50% of synapses and control them. Astrocytes stimulate glycolysis and lactate
synthesis; providing active neurons with metabolic substrates. They functions as
scavengers of ROS as they are a major source of glutathione (Kimelberg &
Nedergaard, 2010; Clarke & Barres, 2013). Astroglia are involved in the pathology
of many chronic neurological disorders where they are referred to reactive astrocytes
with a characteristic up-regulation of GFAP expression (Oberheim et al., 2008).

1.10

Oxidative Stress

1.10.1 Role in Homeostasis

Redox homeostasis is a complex mechanism that can maintain the balance
between ROS production and elimination (Fiedorowicz & Grieb, 2012). ROS are
largely generated from mitochondria as by-products of cellular metabolism at
physiological levels (Thannickal & Fanburg, 2000), such as; superoxide radical
(•O2-), hydrogen peroxide (H2O2), hydroxyl radical (•OH), and singlet oxygen (1O2).
They are scavenged by antioxidants, such as; CAT, GSH, superoxide dismutase, and
much more. Yet, a host of environmental neurotoxicants and other various insults
may enhance their production in the brain, leading to excessive free-radical release
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and resulting in copious amounts of oxidative stress, which can deplete the cell of
endogenous anti-oxidative factors (Beit-Yannai te al., 1997; Burton et al., 2010). The
capacity of ROS interacting and causing damage to proteins, lipids, and
deoxyribonucleic acid (DNA), is a source of significant harmful consequences
occurring to the function of these molecules within the cell (Ogino & Wang, 2007).
The CNS is susceptible to oxygen radicals, in particular the brain because of
its relatively reduced capacity for cellular regeneration and high metabolic rate. The
brain represents only ~2% of the total body weight and demands the highest quantity
of oxygen; more than 20% of the total consumption. The two major cell types in the
brain, neurons and astrocytes, are responsible for this massive consumption of
oxygen and glucose as well. This evidence implicates oxygen radicals in numerous
pathological conditions of the CNS (Halliwell, 2006; Shin et al., 2011; Gandhi &
Abramov, 2012).

1.10.2 Oxidative Stress in Disease

In PD a reduction in GSH and glutathione disulfide (GSSG) was seen in the
substantia nigra (Pearce et al., 1997). These are one of the initial well-known
biochemical indicators of degeneration, and the extent of depletion match the level of
severity of the disease. This was also observed by Sian and colleagues in PD. They
were able to measure GSH levels in the brains of dying patients with PD (Dexter et
al., 1989; Sian et al., 1994). They came to a conclusion that GSH in the brain of PD
is consistent with the concept of oxidative stress as a major component in the
pathogenesis of cell death in PD.
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Oxidative stress, manifested by lipid peroxidation among other indices, was
observed and suggested to be a key feature in AD brain (Bradley-Whitman & Lovell,
2015; Luca et al., 2015). For example, a marker for lipid peroxidation, MDA, has
been identified in the cortex and hippocampus of patients with Alzheimer’s Disease
(Butterfield et al., 2002). The antioxidant enzyme, such as CAT, displayed reduced
activities in affected brain regions in Alzheimer’s disease (Pappolla et al., 1992).
The initiation and progression of epilepsy has implicated oxidative stress as
an etiologic factor in seizures; where prolonged upsurges in ROS carry an integral
risk of increasing neurodegeneration such as that seen in epilepsy (Ashrafi et al.,
2007). Oxidative stress in relation to cell death is a contributing factor in
epileptogenesis, because neuronal cells are considered vulnerable to oxidative
damage and are a consequence of epileptic seizures (Shin et al., 2011). Nevertheless,
raised oxidative stress does not demonstrate that it is involved in the
neurodegeneration that is associated with these disorders. Cells have developed
several defense and repair mechanisms to deal with oxidative stress and associated
damage, however in these conditions, antioxidant defense molecules that would
normally neutralize the injuries of ROS, are reduced.

1.11

Animal Models of Hippocampal Neurodegeneration

Animal models have been used in an attempt to explain a precise cause and
mimic important aspects of pathologies associated with disorders, such as those of
the CNS, and have been successful to reproduce key aspects of disorders in
neuroscience areas. Using animal models in research allows for experimental
manipulation that can produce a hippocampal neuronal loss with possible underlying
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mechanisms that may be similar to those portrayed in neurodegenerative diseases.
For the past few decades, long-term bilateral adrenalectomy-induced death of
hippocampal neuron had been used as a model to study the regulation of apoptosis in
adult neurons (Bye & Nichols, 1998; Bye et al., 2001), behavioral learning in spatial
memory tasks (Conrad & Roy, 1993), and many more.
Chronic studies on adrenalectomy provide insight into functions of the
hippocampus and shed light into mechanisms of neuronal death (Spanswick &
Sutherland, 2010). It was discovered that long-term adrenalectomy of normal rats
caused hippocampal granule cell loss, suggesting that this phenomenon might be a
useful

model

of

experimentally

controlled

neuronal

death

relevant

to

neurodegenerative disorders (Sloviter et al., 1989; Gould et al., 1990a; Sloviter et al.,
1993).
Spanswick and colleagues in 2011 used long-term adrenalectomy as a novel
animal model to examine whether neuronal replacement in the hippocampus can
reverse memory deficits caused by selective degeneration of hippocampal neurons
(Spanswick et al., 2011). Another study used long-term bilateral adrenalectomy to
increase our understanding of how neurons in the hippocampus die and the protective
effect of growth factors against apoptosis (Nichols et al., 2005). The possibility that
this cell death involves a biochemical cascade pertinent to neurodegenerative
diseases proposes that this model may be valuable for studies of neuronal death and
its prevention. Another reason to use ADX is the discrepancy in surgical procedures
used to cause damage to neural structures resembling lesions seen in
neurodegenerative diseases. Such practice may influence the severity and degree of
loss, leading to inconsistencies in results across similar studies. The factors that
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might have contributed to the variations in research outcomes could include, efficacy
of surgery and difference in sensitivity of techniques to measure extent of neuronal
injury (Zola et al., 2000). An example of this is using the anti-mitotic agent
colchicine injections in the DG of rats as a technique to remove granule cells and
study spatial memory (Xavier et al., 1999), which may lead to variable results from
memory experiments due to the unknown extent of damage produced in the
hippocampus (Jeltsch et al., 2001). This obstructs the ability to conclude definite
conclusions about the differences in study results. Despite these limitations, overall
findings support the suggestion that the DG plays an important role in memory
(Sloviter et al., 1993).

33
1.12

Study Rationale and Aim

Long-term bilateral adrenalectomy has been shown to damage the
hippocampal neurons ( Sloviter et al., 1989; Sapolsky et al., 1991; Adem et al., 1994;
Krugers et al., 1994; Sousa et al., 1997; Nichols et al., 2005; Sugama et al., 2013).
Although the effects of long-term adrenalectomy have been studied extensively there
are few publications on the effects of short-term bilateral adrenalectomy (Jaarsma et
al., 1992; Vazquez et al., 1993; Hamadi et al., 2016). We hypothesize that early rise
of neuroinflammation and a reduction in neuronal growth factors trigger
hippocampal neuronal cell death following ADX. In the present study we aimed to
investigate the effects of short-term bilateral adrenalectomy of the hippocampus of
male Wistar rats at different time points (0.5, 2, 4, 12 hours, as well as 1, 3, 7, 14
days) on the:

1. Levels of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α.
2. Levels of growth factors IGF-1 and β-NGF.
3. Response of microglia and astrocytes to neuronal cell death.
4. Oxidative stress markers GSH, CAT, and MDA.
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Chapter 2: Methods
2.1

Animals

Male Wistar rats (n = 8-10) were obtained from the United Arab Emirates
University Animal House. At the onset of the experiment the rats weighed
approximately 160 – 170 grams. Rats were housed five per cage in a 12-hour
light/dark cycle and received ad libitum access to food and water for the duration of
the study. Rats were maintained in a temperature of 22°C. All experimental
procedures were conducted in accordance and with the approval of the UAEU
Animal Ethics committee guidelines.

2.2

Time-Course of Adrenalectomy

Rats underwent either ADX or corresponding Sham surgery (controls). Rats
were weighed and divided in their respective cages 3 days before the surgery to
accustom them to human handling and exposure; this helped to minimize any stress
they may have experienced and will not interfere with the experiment. Both handling
acclimation and housing accommodations were performed to minimize stress, which
can activate the HPA axis and GC secretion. Anesthesia was induced using a 6
mg/ml concentration of pentobarbitone (35 mg/kg, intraperitoneal). A surgical plan
was not needed to be maintained for the surgical procedure, as the procedure
duration lasted 20 minutes and the effect of the anesthesia reached half-life after 30
minutes.
Upon induction, the flanks were shaved and swabbed three times with alcohol
(70% ethanol). ADX involved making an approximately 2 cm long incision through
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the skin in each flank using a number 11 scalpel. Muscle was then blunt dissected.
The adrenal glands were removed using organ forceps. The muscle wall of the
peritoneal cavity was sutured closed with Clini-Gut® (19mm, CliniSut Sutures).
Skin was closed using AutoClip for wounds (9mm, Clay Adams®), and swabbed
with Betadine® (povidone-iodine).
Sham surgery was performed in a similar fashion without the removal of the
adrenal glands. Rats were housed in opaque cages under ultraviolet light for warming
post-surgery to reduce environmental stress (Conrad & Roy, 1993). Immediately
following surgery, all rats were given Trimol® (co-trimoxazole: sulfamethoxazole
40mg/ml + trimethoprim 8mg/ml) 10 ml for 3 days, mixed with their drinking water,
prophylactically against post-surgical infection (Spanswick et al., 2007; Spanswick et
al., 2011).
All ADX rats were provided 0.9 % saline in lieu of drinking water for the
remainder of the experiment in order to maintain electrolyte balance and prevent the
deleterious effects of sodium chloride insufficiency (Krause & Sakai, 2007; R. S.
Sloviter et al., 1989). Rats were weighed before the surgery and at time of sample
collection.

2.3

Sample Collection

Upon euthanasia, at different time points; 0.5, 2, 4, 12 hours, as well as 1, 3,
7, 14 days, the animals were sacrificed by an overdose of pentobarbitone. Blood
from the vena cava was collected and placed in clot activator gel tubes (BD
Vacutainer®). Blood samples were centrifuged at 15,000 rpm (20879 G) for twenty
minutes. The separated serum was removed and stored at -40 °C until the samples
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were assayed. The head was placed on ice while removing the brain. Using surgical
scissors, we made a midline incision in the skin and flipped the skin over the eyes to
free the skull. The skull was removed by making a cut through the anterior part,
between the eyes. We then tilt the parietal and frontal bones to break them off while
taking care of the meninges. Finally, we used a curved narrow forceps under the
olfactory bulb to break the optic nerves. Immediately after placing the brain on a
petri dish filled with ice, the cerebellum was dissected. The cortex was opened from
the midline and removed from both sides of the brain to free the hippocampus. The
hippocampus was dissected by rolling it out of the brain to free it from the cortex
(Spijker, 2011).
The hippocampi were stored in 2 ml microtubes then submerged in liquid
nitrogen for flash freezing. All samples were stored in -40°C.

2.4

Hippocampal Tissue Homogenate

For the assays, the hippocampi samples weighed approximately 80-100
milligrams. Protein extraction was performed by incubating the tissues in Thermo
protein extraction reagent® (T-PER) buffer that contain 25mM bicine and 150mM
sodium chloride (pH 7.6), it was added in a ratio of (1:5) weight to microliter volume
and with (1:100) microliter volume of protease inhibitor. The incubation with the
buffer for 30 minutes on ice was done prior to homogenizing individual samples with
ultra-sonication using a sonic ruptor 250 (OMNI®) for 15 seconds at minimum
speed. To facilitate cross-linking, samples were incubated for another 30 minutes on
ice, and centrifuged in a micro centrifuge for 15,000 rpm (20879 G) (eppendorf®
5417R) for 30 minutes at 4°C. Then the supernatant was collected and placed in 2
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aliquots to reduce the amount of freeze – thaw cycles for multiple quantitative
analyses.

2.5

Corticosterone Analysis

To assess the effectiveness of ADX, approximately 2.0 ml of blood was
collected from each rat. Blood samples were centrifuged at 15,000 rpm for twenty
minutes. The separated serum was used to measure the level of circulating
corticosterone (CORT). A competitive ELISA Corticosterone using R&D Systems®
was performed according to kit instructions.
The quantitative assay was based on a competitive binding technique. A
sheep polyclonal antibody specific to CORT bounded to the microplate, which was
commercially coated with a donkey anti-sheep IgG antibody. That allowed the
CORT present in the samples to compete with horseradish peroxidase – labeled
corticosterone for sites on the polyclonal antibody. A substrate solution consisting of
1:1 hydrogen peroxide and chromogen was added to develop color and determine the
bound enzyme activity. The absorbance was read at 450 nm, and the corresponding
results were indicative of the CORT concentration in the samples.

2.6

Pro-Inflammatory Cytokines Analysis (IL-1β, IL-6, and TNF-α)

Pro-inflammatory cytokines IL-1β, IL-6, and TNF-α are produced in the
brain and are elevated in numerous neuropsychiatric diseases. Various studies on the
hippocampus implicated in neurodegenerative diseases have shown an early
expression of these cytokines at high levels.
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The levels of the cytokines were analyzed using ELISA technique following
the kit instructions. The kit was provided by R&D Systems®. The ELISA plates used
were Nunc maxisorp®. The ELISA plates were initially incubated overnight at room
temperature with the captured/primary antibody for each corresponding cytokine
assay; this will later allow the binding of the capture antibody with the present
cytokine in the hippocampus homogenate sample. Incubating the plates with 1%
bovine serum albumin (BSA) in phosphate-buffered saline (PBS) for 2 hours at room
temperature the next day will block the plates and prevent any false binding with the
walls of the wells. A standard curve is needed to allow the formation of an equation
from the straight line; this permits the extrapolation of the cytokine concentrations in
each sample by performing a serial dilution of known standard protein
concentrations; therefore, standards and samples were added to their respective
wells. After this is done, the plates are once again incubated overnight at room
temperature. The following day, the plates undergo a series of incubation; with the
detection antibody for 1 hour that binds to the cytokines in the sample, and then with
horseradish peroxidase (HRP) for 20 minutes. Finally tetramethylbenzidine was
added to develop the color and a Stop Solution to terminate the reaction. The plates
were read at a wavelength of 450nm.
The cytokine concentrations were calculated against the standard curve and
the final results for the cytokines were normalized to the total protein concentrations
that were attained from the protein assay for each sample.
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2.7

Growth Factors Analysis

2.7.1

Insulin-Like Growth Factor-1 (IGF-1)

IGF-1, a trophic factor for neurons, has also been shown to be an important
regulator of cell metabolism, differentiation, and survival.
The Quantikine® ELISA from R&D Systems® assay was used for the
quantitative determination of rat IGF-1 in tissue homogenate of the hippocampi. A
monoclonal antibody specific for rat IGF-I had been pre-coated onto a microplate.
Any rat IGF-I present in the sample was bound by the immobilized antibody. An
enzyme-linked polyclonal antibody specific for rat IGF-I was added to the wells.
Following the formation of bound antibody-enzyme reagent, a substrate solution
yielded a blue product that turned yellow with the addition of the Stop Solution. The
intensity of the color measured at 450 nm was in proportion to the amount of rat
IGF-I bound in the initial step.

2.7.2

β-Nerve Growth Factor (β-NGF)

β-NGF is a trophic factor for neurons and is involved in the maintenance of
the sympathetic and sensory nervous systems. It exerts a number of different effects
on neurons, such as development, survival, and differentiation. Neurons that fail to
obtain sufficient NGF die by apoptosis. It has been shown that adrenalectomy in
young rats caused a drastic decrease of the NGF level in the hippocampus (Aloe,
1989).
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A DuoSet® ELISA from R&D Systems® assay was used for the quantitative
measurement of rat β-NGF in hippocampal tissue homogenate. It employed a
specific antibody for rat β-NGF, goat anti-rat β-NGF, coated on a 96-well plate. The
β-NGF present in a sample was bound to the wells by the immobilized antibody.
Later, biotinylated goat anti-rat β-NGF antibody was added followed by HRPconjugated

streptavidin.

The

addition

of

the

substrate

solution

(1:1

tetramethylbenzidine and H2O2) allowed color development in proportion to the
amount of β-NGF bound. Finally, the Stop Solution (2 N sulfuric acid ;H2SO4)
changed the color from blue to yellow, and the intensity of the color was measured at
450 nm.

2.8

Oxidative Stress Analysis

Malondialdehyde is a naturally occurring product of lipid peroxidation. Lipid
peroxidation is used as an indicator of oxidative stress in cells and tissues. The
measurement of TBARS is a well-established method for screening and monitoring
lipid peroxidation.
Cayman’s TBARS Assay Kit® was used to assay lipid peroxidation in
hippocampal tissue homogenates. An MDA-TBA adduct (Fig. 11) was formed by the
reaction of MDA and Thiobarbituric Acid (TBA) when placed in boiling water of 90100°C and acidic conditions. The adduct was then measured colorimetrically at 540
nm wavelength using the Infinite M200pro (Tecan®).
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Figure 11: MDA-TBA Reaction

GSH is the key antioxidant in animal tissues. It is present inside cells mainly
in the reduced form (90-95% of the total glutathione). Intracellular GSH status
appears to be a sensitive indictor of the overall health of a cell, and of its ability to
resist toxic challenge.
The glutathione assay kit from Sigma-Aldrich® was used to measure the
level of total glutathione (GSSH + GSH) in the hippocampal tissue homogenate. The
samples were first deproteinized with 5% 5-Sulfosalicylic Acid Solution, next
centrifuged to remove the precipitated protein, and then assayed for glutathione.
GSH was oxidized by the sulfhydryl reagent 5, 5′-dithio-bis (2-nitrobenzoic
acid) (DTNB) to form the yellow derivative 5′-thio-2-nitrobenzoic acid (TNB) and
GSSH (Fig. 12). The GSSG formed was recycled to GSH by glutathione reductase in
the

presence

of

NADPH

(Fig.

13)

and

the

TNB

was

measured

spectrophotometrically. The plate reader was set at a wavelength of 412 nm, with
kinetic reading at 1 minute interval for 5 minutes.

Figure 12: GSH Oxidation
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Figure 13: GSSH Reduction

CAT is a ubiquitous antioxidant enzyme that is present in most cells. CAT is
involved in the detoxification of H2O2, a ROS, which is a toxic product. This enzyme
demonstrates catalytic activity and peroxidatic activity (Fig. 14).

Figure 14: CAT Detoxication of Hydrogen Peroxide

Cayman’s Catalase Assay Kit® was employed to measure CAT activity in
tissue homogenates of the hippocampus. It utilized the peroxidatic function of CAT
for determination of enzyme activity. The method was based on the reaction of CAT
with methanol in the presence of H2O2. Formaldehyde was produced and measured
colorimetrically with 4-amino-3-hydrazino-5-mercapto-1, 2, 4-triazole (Purpald) as
the chromogen. It specifically formed a bicyclic heterocycle with aldehydes, which
upon oxidation changed from colorless to a purple color. The absorbance was read at
540 nm wavelength.
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2.9

Immunohistochemistry

In order to determine a time-course of ADX-induced cell death, ADX and
sham

operations

were

performed

on

male

Wistar

rats

(n=32)

for

immunohistochemical examination. At varying time points; 1 day, 3 day, 7 day, and
14 day, animals were anesthetized with a lethal dose of sodium pentobarbital (>35
mg/kg, intraperitoneal). A perfusion-fixation procedure was done transcardially; by
first cutting open the right atrium to allow the removal of circulating blood, with 50
ml of 0.1 M phosphate-buffered saline perfused by inserting a needle through the
ascending aorta, followed by 300 ml of 4% formaldehyde in 0.1 M PBS to fix the
tissue and prevent any denaturing of proteins.
Brains were removed and stored in the same fixative for 1 week. The tissues
were then run through an ethanol series for dehydration, cleared in 100% xylene, and
embedded in paraffin wax. Blocks were ready to be sectioned on a rotating
microtome. Coronal Sections were taken at 1μm and mounted on gelatin subbed
slides. The tissues were then prepared for fluorescent labeling.. The sections were
deparaffinized with xylene series at 5 minutes each, rehydrated with an ethanol series
(100, 90, 80, and 70%) also at 5 minutes each, and washed in distilled water for 5
minutes. Then tissues underwent an antigen retrieval technique with 10mM Sodium
Citrate (pH 6), trailed by microwave heating for 1 minute at high power followed by
10 minute at low power; this allowed for proficient immunostaining. Finally, sections
were washed with 0.1 M PBS (pH 7.4) and cooled down at room temperature.
Double immunofluorescence labeling was done by first blocking the sections
with 1% BSA buffer for 30 minutes at room temperature. Afterward, the primary
antibodies were added to the slides and left for incubation overnight at 4°C. Ionized
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calcium-binding adaptor molecule-1 (Iba-1) is a protein that is specifically expressed
in microglia and is up regulated during the activation of these cells, and these
antibodies are specifically reactive to microglia and are also appropriate for
immunodouble staining of brain tissues. Neuronal Nuclei (NeuN) antibody
specifically recognizes the DNA-binding, neuron-specific protein NeuN, which is
present in the brain. GFAP is a gene that encodes one of the major intermediate
filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes
from other glial cells during development.
So for the primary antibodies we used rabbit polyclonal anti-ionized calciumbinding adaptor molecule 1 (Iba1, Wako, MA, USA 1:2000) mixed with mouse
monoclonal anti-neuronal nuclear antigen (NeuN, Millipore, MA, USA, 1:1000).
And rabbit polyclonal anti-glial fibrillary acidic protein (GFAP, Dako, Copenhagen,
Denmark, 1:1000) was mixed with mouse monoclonal anti-neuronal nuclear antigen
(NeuN, Millipore, MA, USA, 1:1000). The following day, the sections were washed
several times in PBS, and then tissue sections were incubated with secondary
antibodies. We used donkey anti-rabbit conjugated to Alexa 488 (Invitrogen, Paisley,
UK, 1:200) mixed with donkey anti-mouse conjugated to Rhodamine (Jakson,
Pennsylvania, USA, 1:100). The antibodies were diluted in PBS-Triton X-100 0.3%
for 1 hour at room temperature. Later, the sections were washed in PBS several
times; and cover slipped with a fluoromount medium.

2.10

Statistics

All statistical analyses were conducted using the IBM SPSS Statistics
program version 21; we employed t-test for equality of means with a confidence
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interval 95% of difference. Our data was presented as mean ± standard error mean
and a p-value ≤ 0.05 was considered as significant.
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Chapter 3: Results
3.1

Corticosterone

ADX surgery resulted in significantly lower CORT levels compared to sham
operated rats (Fig. 15). At 0.5h the CORT concentration for ADX rats (1.11 ±
0.59ng/ml) was significantly (P<0.001) lower compared to sham operated rats (64.17
± 8.26ng/ml). After ADX at 2h (0.03 ± 0.01ng/ml), rats also showed a significantly

Serum Corticosterone (ng/ml)

(P<0.001) reduced CORT level compared to sham operated rats (50.34 ± 7.04ng/ml).
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Figure 15: Bar graph showing levels of plasma corticosterone. Levels of
corticosterone in the serum of adrenalectomized rats compared to the sham operated
rats over the course of time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days, and 14 days).
**P<0.01; ***P<0.001. Data are expressed as mean (±SEM)
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The CORT levels were significantly (P<0.01) reduced in the serum of 4 hr
ADX rats (0.16 ± 0.16ng/ml) compared to sham operated rats (17.07 ± 4.81ng/ml).
While at later time-points, circulating CORT levels were undetectable by the kit at
concentrations lower than 0.103 ng/ml. A significant effect of post-surgical time was
present for sham operated rats. Mean CORT levels were 64.17 ± 8.26, 50.34 ± 7.04,
17.07 ± 4.81, 18.02 ± 4.93, 19.14 ± 7.52, 13.95 ±7.03, 16.45 ± 4.60, and 15.00 ±
1.18ng/ml at the 0.5-hour, 2-hour, 4-hour, 12-hour, 1-day, 3-day, 7-day, and 14-day
time-points respectively.

3.2

Pro-Inflammatory Cytokines

Our results show a clear elevation of pro-inflammatory cytokines at early
time points of ADX. IL-6 levels at 2 hours after the surgery were significantly
increased (P<0.05) in the hippocampus of ADX rats compared to sham operated rats.
The increase is seen to be consistent at 4 hours (P<0.01), 1 day (P<0.01), and 3 days
(P<0.001). However, 12 hours, 7 days, and 14 days showed no significant changes
(Fig. 16).
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Figure 16: Bar graph showing IL-6 level in the hippocampus of adrenalectomized
rats and sham operated rats. IL-6 level was measured by ELISA over the course of
time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days, and 14 days). *P<0.05; **P<0.01;
***P<0.001. Data are expressed as mean (±SEM)

As for the pro-inflammatory cytokine IL-1β, a significant rise in levels were
detected in the hippocampus 4 hr (P<0.001), 1 day (P<0.01), 3 days (P<0.05), and 7
days (P<0.001) after ADX compared to the sham animals. No significant changes
were observed at the 0.5 hr, 2 hr, 12 hr, and 14 day post ADX (Fig. 17).
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Figure 17: Bar graph showing IL-1β level in the hippocampus of adrenalectomized
rats and sham operated rats. IL-1β level was measured by ELISA over the course of
time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days, and 14 days). *P<0.05; **P<0.01;
***P<0.001. Data are expressed as mean (±SEM)

Regarding TNF-α, significant increases were seen as early as 2 hours
(P<0.05), 4 hours (P<0.05), and at 12 hours (P<0.001) in the hippocampus of ADX
rats. However, except at 14 days no significant differences in ADX compared to
sham operated rats were seen at 1, 3, and 7 days(P<0.01), (P<0.05), and (P<0.001)
respectively (Fig. 18).
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Figure 18: Bar graph showing TNF-α level in the hippocampus of adrenalectomized
rats and sham operated rats. TNF-α level was measured by ELISA over the course of
time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days, and 14 days). *P<0.05; ***P<0.001.
Data are expressed as mean (±SEM)

3.3

Growth Factors

Using the ELISA method our results showed differences in IGF-1 protein
levels. In the hippocampus, the IGF-1 protein levels were significantly decreased
compared with those of control animals starting at 12h (P<0.01) after ADX. The
results remained consistently low at 1 day (P<0.01), 3 days (P<0.05), 7 days
(P<0.01), and 14 days (P<0.05) after ADX compared to control animals (Fig. 19).
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Figure 19: Bar graph showing IGF-1 level in the hippocampus of adrenalectomized
rats and sham operated rats. IGF-1 level was measured by ELISA over the course of
time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days, and 14 days). *P<0.05; **P<0.01.
Data are expressed as mean (±SEM)

Our results showed a significant decrease (P<0.05) in β-NGF levels only at
14 days after ADX compared to sham operated animals of the same group. There
was no statistical difference between the groups prior to 14 days (Fig. 20).
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Figure 20: Bar graph showing β-NGF level in the hippocampus of adrenalectomized
rats and sham operated rats. β-NGF level was measured by ELISA over the course of
time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days, and 14 days). *P<0.05. Data are
expressed as mean (±SEM)

3.4

Immunohistochemistry

To assess neurodegeneration due to ADX, we looked at microglia upregulation, a major sign of cell death. We labeled the brain tissues of 1 day, 3 days, 7
days, and 14 days with a double immunofluorescent technique, using antibodies
NeuN for neurons and Iba-1 for microglia.
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Figure 21: Images of coronal sections of the hippocampus stained with NeuN
antibody (red) as a neuronal marker and Iba-1 antibody (green) as a microglia
marker. The image shows the progression of microgliosis over the course of time (1
day, 3 days, 1 week, and 2 weeks) in the upper blade of the DG of the hippocampus
of adrenalectomized rats compared to sham operated rats

The resulting images of coronal sections of the hippocampus show the
progression of microgliosis over the course of time in the upper blade of the DG of
adrenalectomized rats compared to sham operated rats. The outcomes of Iba-1
antibody staining did not show activated microglia in adrenalectomized and sham
operated groups at day 1 after ADX (Fig. 21A' and A). At 3 days after ADX, in the
dorsal blade of the DG of rats we detected activated microglia, whereas sham
operated rats showed no sign of activated microglia (Fig. 21B' and B).
Iba-1 labeling exhibited activated microglia throughout the DG following 7
days ADX, this indicated a progression in microgliosis (Fig. 21C'). In contrast, sham
operated rats; there was no staining of Iba-1 antibody in the DG of the hippocampus
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at this time-point (Fig. 21C). At the 14 day time-point following surgery, the double
immunofluorescence labeling was intensely evident in the DG of the hippocampus of
ADX rats (Fig. 21D'), on the other hand, sham operated rats revealed no activated
microglia (Fig. 21D).
In order to see the extent of the spread of the microglia over the whole
dentate gyrus we labeled brain tissues of 14 days with an immunofluorescent
technique using the antibodies Iba-1 for microglia. Our results show a total invasion
of the whole dentate gyrus by microglia.

Figure 22: Images of coronal sections of the hippocampus stained with Iba-1
antibody (green) as a microglia marker. The image shows the extent of microgliosis
at 14 days in the DG of the hippocampus of ADX rats compared to sham operated
rats
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Astrocyte activity in the hippocampus was studied at 1 day, 3 days, 7 days,
and 14 days after ADX. The rat brain tissues were stained using immunofluorescent
antibodies, NeuN for neurons and GFAP for astrocytes.

Figure 23: Images of coronal sections of the hippocampus stained with NeuN
antibody (red) as a neuronal marker and GFAP antibody (green) as an astrocytes
marker. The image shows the progression of astrogliosis over the course of time (1
day, 3 days, 1 week, and 2 weeks) in the upper blade of the DG of the hippocampus
of adrenalectomized rats compared to sham operated rats

The images of coronal sections of the hippocampus show the progression of
astrogliosis over the course of time in the upper blade of the DG of ADX rats
compared to sham operated rats.
Importantly, the upper blade of the DG at 1 day and 3 day time-points did not
show any observable change in the GFAP immunoreactivity between the hippocampi
of adrenalectomized and sham groups (Fig. 23A' and 23B').
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The activated astrocytes appeared at 7 days after ADX in the upper blade of
the DG in the hippocampus (Fig. 23C') compared to the control (Fig. 23C). We were
able to observe a strong immunoreactivity of GFAP antibodies in the hippocampus
of 14-day adrenalectomized rats, with activated astrocytes appearing along the DG
(Fig. 23D'). Sham operated rats did not show any astrogliosis at the same time-point.
In order to see the extent of the spread of the astrocytes over the whole
dentate gyrus we labeled brain tissues of 14 days with an immunofluorescent
technique using the antibodies GFAP for astrocytes. Our results show a total invasion
of the whole dentate gyrus by astrocytes.

Figure 24: Images of coronal sections of the hippocampus stained with GFAP
antibody (green) as an astrocytes marker. The image shows the extent of astrogliosis
at 14 days in the DG of the hippocampus of adrenalectomized rats compared to sham
operated rats

3.5

Oxidative Stress
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The levels of oxidative stress markers MDA, GSH, and CAT in the
hippocampal homogenates of adrenalectomized and sham operated rats were
examined by ELISA over the course of time (0.5h, 2h, 4h, 12h, 1 day, 3 days, 7 days,
and 14 days).
The levels of MDA were significantly increased in the hippocampus of
adrenalectomized rats compared to bilateral sham operated rats after 7 days (P<0.01)
and 14 days (P<0.001) of surgery (Fig. 25). However, at 0.5 hr, 2 hr, 4 hr, 12 hr, 1
day, 3 days, and 7 days before surgery no change was seen in the hippocampal levels
of MDA between the two groups.
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Figure 25: Bar graph showing MDA levels in the hippocampus of
adrenalectomized and sham operated rats. Levels of MDA were measured by
colorimetric assay over course of time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days,
and 14 days) in adrenalectomized rats compared to sham operated rats. **P<0.01;
***P<0.001. Data are expressed as mean (±SEM)
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A significant decrease in GSH levels was observed in the hippocampus 7
days (P<0.05) and 14 days (P<0.001) after ADX, however, no statistical difference in
GSH levels were seen before one week (Fig. 26).
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Figure 26: Bar graph showing GSH levels in the hippocampus of
adrenalectomized and sham operated rats. Levels of GSH were measured by
colorimetric assay over course of time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days,
and 14 days) in adrenalectomized rats compared to sham operated rats. ***P<0.001.
Data are expressed as mean (±SEM)

The levels of CAT were significantly increased in the hippocampus of
adrenalectomized rats compared to bilateral sham operated rats after 3 days (P<0.01),
7 days (P<0.05), and 14 days (P<0.05) only (Fig. 27).
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Figure 27: Bar graph showing CAT levels in the hippocampus of
adrenalectomized and sham operated rats. Levels of CAT were measured over course
of time (0.5 h, 2 h, 4 h, 12 h, 1 day, 3 days, 7 days, and 14 days) in adrenalectomized
rats compared to sham operated rats. *P<0.05; **P<0.01. Data are expressed as mean
(±SEM)
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Chapter 4: Discussion

Bilateral adrenalectomy has been shown to damage the hippocampal neurons.
Although the effects of long-term adrenalectomy have been studied extensively there
are few publications on the effects of short-term adrenalectomy ( Jaarsma et al.,
1992; Vazquez et al., 1993; Hamadi et al., 2016). In this thesis we aimed to
investigate the effects of short-term bilateral adrenalectomy on the levels of proinflammatory cytokines IL-6, IL-1β, and TNF-α; levels of growth factors, the
response of microglia and astrocytes to neuronal cell death as well as oxidative stress
markers MDA, GSH, and CAT over the course of time in the hippocampus of Wistar
rats.
Bilateral adrenalectomy significantly reduced serum CORT levels across all
time points in rats compared to sham operated rats. These findings are in line with
previous findings showing that bilateral removal of the adrenal glands in the adult rat
produces a complete and immediate loss of CORT in the serum of ADX rats
(Sloviter et al., 1989; Islam et al., 1999b). In control rats, high levels of CORT were
seen early after the surgeries were performed, this is likely due to the stress generated
from the procedure itself.
In this study we investigated the levels of inflammatory cytokines in the
hippocampus of ADX and sham operated rats at different time points. Our results
showed an early onset of pro-inflammatory cytokines elevation in the brain of ADX
rats. IL-6 was significantly increased in hippocampus of ADX rats at 2 hours, 4
hours, 1 day, and 3 days. While, IL-1β levels were also significantly elevated after
ADX at 4 hours, 1 day, 3 days, and 7 days. TNF-α was significantly increased in
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hippocampus of ADX rats at a very early time point of 2 hours, 4 hours, and 12
hours. However, it appeared to be raised prominently at 14 days. In this study the
early elevation of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α was
observed prior to neuronal death. These findings are in line with several studies in
which an early increase of different pro-inflammatory cytokines preceded neuronal
damage (Minami et al., 1991;; Tchelingerian et al., 1993; Pearson et al., 1999;
Rothwell, 2003; Liu et al., 2005; Zhu et al., 2006).
The involvement of IL-1β in neurodegeneration has been shown by different
groups (Lawrence et al., 1998; Panegyres & Hughes, 1998; Rothwell, 2003). Mice or
rats exposed to neurotoxins showed markedly exacerbated neurodegeneration when
low doses of IL-1β were injected into the cerebral ventricles or brain parenchyma.
Moreover, the co-infusion of IL-1β with IL-1β receptor antagonist inhibits the brain
damage induced by the excitotoxin NMDA (Lawrence et al., 1998; Panegyres &
Hughes, 1998). Furthermore, IL-1β is implicated in the pathology of several
neurodegenerative diseases such as multiple sclerosis, Alzheimer’s disease and other
CNS chronic diseases (Pearson et al., 1999; Allan & Rothwell, 2001; Boutin et al.,
2001; Griffin & Mrak, 2002). IL-6 levels were also found to be elevated in different
neurological diseases (Blum-Degen et al., 1995;;; Stelmasiak et al., 2001; Berti et al.,
2002; Malmestrom et al., 2006; Lucin & Wyss-Coray, 2009).The early elevations of
IL-1β, IL-6, and TNF-α observed after ADX might have a contribution to the
initiation of the biological cascade responsible for subsequent hippocampal neuronal
cell death.
Alteration of IGF-1 receptor and its messenger ribonucleic acid (mRNA)
after long-term adrenalectomy were previously studied in the hippocampus by in
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vitro receptor autoradiography and in situ hybridization immunohistochemistry,
respectively. Significantly decreased levels of IGF-1 receptor and its mRNA were
noted in the DG and CA1–CA4 regions of the hippocampus after long-term
adrenalectomy suggesting that the level and expression of IGF-1 receptors in the
hippocampus is influenced by adrenal hormones (Islam et al., 1998). In this thesis
after short-term bilateral adrenalectomy of rats there was a significant reduction of
IGF-1 levels in the hippocampus at 12 hours, 1 day, 3 days, 7 days, and 14 days. The
level of IGF-1 was significantly reduced at 12 hours after ADX, this is seen long
before the death of the neurons (day 3), and the appearance of the microglia (day 3)
and astrocytes (day 7). However, the total loss of CORT and significant increase of
inflammatory cytokines precedes the loss of IGF-1. Our results suggest that IGF-1
might have a neuroprotective role in the hippocampus. Interestingly, several studies
have shown a rescuing effect of IGF-1 on cognitive functions in pathological
conditions (Stern et al., 2014). It could be speculated that ADX may increase
susceptibility of hippocampal neurons to degeneration through early changes in IGF1 levels.
The level of β-NGF in young adult rat hippocampus was also found to be
significantly decreased after ADX (Aloe, 1989). These findings are in line with our
finding that β-NGF levels were significantly reduced in the hippocampus 14 days
after ADX. It is possible that other trophic factors which have impact on
hippocampal neurons might also be affected after ADX.
After bilateral adrenalectomy Sloviter et al (1989) performed Nissl staining
of the rat hippocampus and revealed cell loss was bilateral and the neuronal
degeneration first appeared at the lateral end of the upper blade of the DG (Sloviter et
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al., 1989). These findings were replicated by several others (Sapolsky et al., 1991;
Adem et al., 1994; Hamadi et al., 2016;). The cell death due to ADX occurs at
approximately 3 days after the surgery was performed (Gould et al., 1990a;
Spanswick et al., 2011; Hamadi et al., 2016). Interestingly, the lateral end of the
upper blade of the DG where neuronal degeneration first appears is where the
microglia and astrocytes appear after bilateral adrenalectomy. One of the major signs
of neurodegeneration is the activation of microglia (Lucin & Wyss-Coray, 2009). We
found significant increase of activated microglia around the dorsal blade of the DG 3
days after ADX. These findings support the observation by Gould et al (Gould et al.,
1990b) which reported that cell death starts in the dorsal blade of the DG 3 days after
ADX. Furthermore, our study shows that the number of activated microglia around
the dorsal blade increased significantly one week after ADX and the whole DG was
invaded by activated by microglia two weeks after the operation.
Increased astrocytes reactivity is associated with brain injury (Fiedorowicz et
al., 2001). By increasing both their number and size astrocytes react to brain damage
or disease. In this study we showed significant increases in GFAB immunoreactivity
in the hippocampus at 7 days and 14 days after ADX.

The molecular and

polymorphous layers of the DG showed astrogliosis during the first week.
It is well known that the communication between astrocytes and microglia
plays an important role in different pathological conditions (Verderio & Matteoli,
2001; von Bernhardi & Ramirez, 2001). Our results showed an early activation of
microglia followed by activation of astrocytes on the third and seventh day
respectively after ADX. Similar results were obtained in different neurodegenerative
models where the microglia were first activated in response to neuronal damage
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followed by astrocytes activation (Matsumoto et al. 1992; Frautschy et al., 1998;
Gahtan & Overmier, 1999; Reali et al., 2005). Taken together these findings suggest
that during neuronal damage there is a cross talk between microglia and astrocytes
and that the former is considered as the driving force in recruiting the astroglia.
Accumulation or overproduction of ROS in conjunction with reduced
antioxidant capacity within the cell results in oxidative stress (Sies, 1997). Microglia
become functionally active as a result of neuronal death and up-regulate enzymes
such as inducible nitric oxide synthase (iNOS) leading to an imbalance between free
radicals production and the antioxidant defenses (Tran et al., 1997). One week after
ADX an overexpression of iNOS in activated microglia revealing these cells as the
source of the free radical in this model (Sugama et al., 2013). The antioxidant CAT
was observed to increase at 3, 7, and 14 days in an effort to protect the neurons.
However, a state of oxidative stress was manifested in the significant decrease of
GSH 1 week and 2 weeks and simultaneous increase of MDA the indicator of the
plasma membrane disruption 1 week and 2 weeks after ADX. These results are in
line with the literature showing that several neurodegenerative models revealed the
association between neuro-inflammation accompanied by reactive gliosis and a state
of oxidative stress (Zhu et al., 2004).
The mechanisms underlying neuronal degeneration after bilateral
adrenalectomy are not clear. The possibility that adrenocortical hormones might have
direct effects on the survival of hippocampal neurons was previously suggested
(Adem et al., 1994; Islam et al., 1999b). Hippocampal neurons might die when the
mineralocorticoids (Type I) and/or glucocorticoid (Type II) receptors are not
occupied by adrenocortical hormones (Adem et al., 1994; Islam et al., 1999a). Hu et
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al reported that granule cell death after adrenalectomy was accompanied by the
disappearance of GC receptor immunoreactivity in the granule cell layer (Hu et al.,
1997). We have also previously suggested that the loss of adrenocortical hormones
after ADX may cease to stimulate a factor(s), in the hippocampus, that is (are)
necessary for the survival of hippocampal neurons (Adem et al., 1994; Islam et al.,
1999b). In this respect our findings show early loss of IGF-1, before the start of
neuronal degeneration and glial activation/migration, in the hippocampus after ADX.
It could be speculated that ADX may increase susceptibility of hippocampal neurons
to degeneration through early changes in IGF-1 levels.

4.1

Conclusions

Our study showed that short-term bilateral adrenalectomy leads to an early
increase in pro-inflammatory cytokines and decrease in growth factors followed by
neurodegeneration and activation of glial cells as well as oxidative stress. Taking
these findings together it could be suggested that the early inflammatory components
and loss of growth factors might contribute to the initiation of the biological cascade
responsible for subsequent hippocampal neuronal cell death in the current
neurodegenerative animal model (See Fig. 28). It could be speculated that in several
neurodegenerative diseases like Alzheimer’s disease, chronic adrenal hormones
increase and/or their receptors’ decrease may result in inflammatory mechanisms and
loss of growth factors like IGF-1 which may lead to hippocampal neurodegeneration.
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Figure 28: Cascade of neurodegeneration

4.2

Strengths and Limitations

Several strengths and limitations of our study should be recognized. A major
strength of the study includes the well-performed ADX. No weight gain or death of
subjects was seen. One limitation of our study is that the rats did not undergo spatial
learning and memory performance tasks before or after experimental surgery which
limited our ability to assess more specific associations between neurodegenerative
alterations after short- term adrenalectomy and cognitive decline.

4.3

Future Studies

Future studies will be needed to investigate possible associations between
memory performance and short-term bilateral adrenalectomy. Studying additional
effects of ADX on the hippocampus are needed in order to understand the
neurodegenerative processes involved in this animal model.
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